Temozolomide and treatment of malignant glioma.

590 indexed citations
published 2000
Authors
Henry S. FriedmanTracy KerbyHilary Calvert
Journal
PubMed

In The Last Decade

doi.org/w27732870 →

Countries where authors are citing Temozolomide and treatment of malignant glioma.

Specialization
Citations

This map shows the geographic impact of Temozolomide and treatment of malignant glioma.. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Temozolomide and treatment of malignant glioma. with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Temozolomide and treatment of malignant glioma. more than expected).

Fields of papers citing Temozolomide and treatment of malignant glioma.

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Temozolomide and treatment of malignant glioma.. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Temozolomide and treatment of malignant glioma..

About Temozolomide and treatment of malignant glioma.

This paper, published in 2000, received 590 indexed citations . Written by Henry S. Friedman, Tracy Kerby and Hilary Calvert covering the research area of Molecular Biology, Oncology and Genetics. It is primarily cited by scholars working on Molecular Biology (308 citations), Genetics (281 citations) and Cancer Research (130 citations). Published in PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/w27732870.

Explore hit-papers with similar magnitude of impact

Breakdown of academic impact, for the paper The Ancient Drug Salicylate Directly Activates AMP-Activated Protein KinaseBreakdown of academic impact, for the paper Genetic Control of Surface CurvatureBreakdown of academic impact, for the paper Engineered antibody Fc variants with enhanced effector functionBreakdown of academic impact, for the paper Commensal bacteria protect against food allergen sensitizationBreakdown of academic impact, for the paper Noninvasive Detection of Response and Resistance in EGFR -Mutant Lung Cancer Using Quantitative Next-Generation Genotyping of Cell-Free Plasma DNABreakdown of academic impact, for the paper Vertex algebras for beginnersBreakdown of academic impact, for the paper The Sustainability Liability: Potential Negative Effects of Ethicality on Product PreferenceBreakdown of academic impact, for the paper Epidemiology and social costs of hip fractureBreakdown of academic impact, for the paper Phase engineering of nanomaterialsBreakdown of academic impact, for the paper The detection of psychiatric illness by questionnaire : a technique for the identification and assessment of non-psychotic psychiatric illness
Rankless by CCL
2026